Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Helicobacter Pylori Infections Market : Reviews of Drug Profiles, Products & Key Players

% of readers think this story is Fact. Add your two cents.


Helicobacter Pylori Infections – Pipeline Review, H1 2014

Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on [email protected] with Helicobacter Pylori Infections Market in subject line and your contact details.

Helicobacter Pylori Infections – Pipeline Review, H1 2014, provides an overview of the Helicobacter Pylori Infections’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Helicobacter Pylori Infections Market, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Helicobacter Pylori Infections and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Complete report is spread across 79 pages and available @ http://www.reportsnreports.com/reports/280058-helicobacter-pylori-infections-pipeline-review-h1-2014.html.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

- The report provides a snapshot of the global therapeutic landscape of Helicobacter Pylori Infections
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Helicobacter Pylori Infections and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects

- A review of the Helicobacter Pylori Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Helicobacter Pylori Infections pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=280058.

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Helicobacter Pylori Infections
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Helicobacter Pylori Infections pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=280058.

List of Tables
Number of Products under Development for Helicobacter Pylori Infections, H1 2014 9
Number of Products under Development for Helicobacter Pylori Infections – Comparative Analysis, H1 2014 10
Number of Products under Development by Companies, H1 2014 12
Number of Products under Investigation by Universities/Institutes, H1 2014 13
Comparative Analysis by Late Stage Development, H1 2014 14
Comparative Analysis by Clinical Stage Development, H1 2014 15
Comparative Analysis by Early Stage Development, H1 2014 16
Comparative Analysis by Unknown Stage Development, H1 2014 17
Products under Development by Companies, H1 2014 18

Products under Investigation by Universities/Institutes, H1 2014 19
Helicobacter Pylori Infections – Pipeline by Sequella, Inc., H1 2014 20
Helicobacter Pylori Infections – Pipeline by Takeda Pharmaceutical Company Limited, H1 2014 21
Helicobacter Pylori Infections – Pipeline by Affinium Pharmaceuticals, Ltd., H1 2014 22
Helicobacter Pylori Infections – Pipeline by Microbio Co., Ltd., H1 2014 23
Helicobacter Pylori Infections – Pipeline by MerLion Pharmaceuticals Pte Ltd, H1 2014 24
Helicobacter Pylori Infections – Pipeline by ImmunoBiology Ltd., H1 2014 25
Helicobacter Pylori Infections – Pipeline by EpiVax, Inc., H1 2014 26
Helicobacter Pylori Infections – Pipeline by aRigen Pharmaceuticals, Inc., H1 2014 27
Helicobacter Pylori Infections – Pipeline by Vecta Ltd., H1 2014 28
Helicobacter Pylori Infections – Pipeline by Sigmoid Pharma Ltd., H1 2014 29
Helicobacter Pylori Infections – Pipeline by RedHill Biopharma Ltd., H1 2014 30
Assessment by Monotherapy Products, H1 2014 31
Assessment by Combination Products, H1 2014 32
Number of Products by Stage and Target, H1 2014 35
Number of Products by Stage and Mechanism of Action, H1 2014 38
Number of Products by Stage and Route of Administration, H1 2014 40
Number of Products by Stage and Molecule Type, H1 2014 42
Helicobacter Pylori Infections Therapeutics – Recent Pipeline Updates, H1 2014 65
Helicobacter Pylori Infections – Dormant Projects, H1 2014 69

Inquiry Before Buying @ http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=280058.

List of Figures
Number of Products under Development for Helicobacter Pylori Infections, H1 2014 9
Number of Products under Development for Helicobacter Pylori Infections – Comparative Analysis, H1 2014 10
Number of Products under Development by Companies, H1 2014 11
Comparative Analysis by Clinical Stage Development, H1 2014 15
Comparative Analysis by Early Stage Products, H1 2014 16
Assessment by Monotherapy Products, H1 2014 31
Assessment by Combination Products, H1 2014 32
Number of Products by Top 10 Target, H1 2014 33
Number of Products by Stage and Top 10 Target, H1 2014 34
Number of Products by Top 10 Mechanism of Action, H1 2014 36
Number of Products by Stage and Top 10 Mechanism of Action, H1 2014 37
Number of Products by Top 10 Route of Administration, H1 2014 39
Number of Products by Stage and Top 10 Route of Administration, H1 2014 40
Number of Products by Top 10 Molecule Type, H1 2014 41
Number of Products by Stage and Top 10 Molecule Type, H1 2014 42

Explore Report on Pharmaceuticals & Therapeutic Market.

Contact [email protected] / Call +1 888 391 5441 for further information on “Helicobacter Pylori Infections – Pipeline Review, H1 2014” report OR for any other market research and intelligence needs you may have for your business.



Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST


Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.

Report abuse
Loading...

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.